{
  "success": true,
  "pagesUsed": [
    2,
    4,
    6,
    10,
    11,
    15,
    16,
    20,
    22,
    23,
    27,
    28,
    40,
    41,
    44,
    45,
    46,
    56,
    58
  ],
  "modelUsed": "gemini-3-flash-preview",
  "confidence": 0.8666666666666667,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "Screening Window",
        "type": {
          "id": "d26f1734-de5d-47bf-9872-869996970d4c",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P8W",
        "valueLabel": "8 weeks",
        "relativeToFrom": {
          "id": "bd4b6aeb-94c6-4883-8737-64f4f61a2864",
          "code": "C71154",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Randomization",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "503f4a42-a8a1-4c3f-b829-1bc459a08ef6",
        "instanceType": "Timing",
        "windowLower": "-P56W",
        "windowUpper": "-P21W"
      },
      {
        "id": "timing_2",
        "name": "Screening Extension",
        "type": {
          "id": "f345ef55-e5b2-4508-8a34-a96e6edc9d2b",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P2W",
        "valueLabel": "2 weeks",
        "relativeToFrom": {
          "id": "119556d0-1ecb-4f1d-9816-1d57423b00fa",
          "code": "C71158",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Screening",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "966d3337-2841-4980-9780-8796e77f6bf4",
        "instanceType": "Timing",
        "windowLower": "P0W",
        "windowUpper": "P14W"
      },
      {
        "id": "timing_3",
        "name": "Single-Blind Placebo Run-in",
        "type": {
          "id": "55296338-7556-4daa-aca0-fb10b15ade32",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P2W",
        "valueLabel": "2 weeks",
        "relativeToFrom": {
          "id": "259a44c4-6ecc-4aa8-8e1c-eb8fb6432cbf",
          "code": "C71154",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Randomization",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "b98989f3-e414-4ad1-98be-cff685522ff5",
        "instanceType": "Timing",
        "windowLower": "-P14W",
        "windowUpper": "-P1W"
      },
      {
        "id": "timing_4",
        "name": "ACEi/ARB Stability Period",
        "type": {
          "id": "c1f66548-92bb-4327-9183-187263ed2ef3",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P4W",
        "valueLabel": "4 weeks",
        "relativeToFrom": {
          "id": "7ed6f752-b882-4f84-a3c3-ec0886c234ca",
          "code": "C71154",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Randomization",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "73727239-0c3a-4810-9f91-0f0f117872b3",
        "instanceType": "Timing",
        "windowLower": "-P28W",
        "windowUpper": "P0W"
      },
      {
        "id": "timing_5",
        "name": "Post-Treatment Follow-up",
        "type": {
          "id": "2ef9544b-ac14-4616-a5b2-bcf0460bc7de",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "P30D",
        "valueLabel": "Day 30",
        "relativeToFrom": {
          "id": "8e771020-21ae-412d-b840-9489a0fc061c",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "fd177632-81b8-4ea6-adc7-654b2fb34a8a",
        "instanceType": "Timing",
        "windowLower": "P18D",
        "windowUpper": "P42D"
      },
      {
        "id": "timing_6",
        "name": "Endpoint Confirmation Window",
        "type": {
          "id": "c6074640-0d8a-4b2b-82a1-e82670b1d969",
          "code": "C71152",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Between",
          "instanceType": "Code"
        },
        "value": "P30D",
        "valueLabel": "Day 30",
        "relativeToFrom": {
          "id": "e3a6ffc0-0553-45f6-8ebb-225fdffd13e3",
          "code": "C71159",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Baseline",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "d6e61ea2-faef-402d-a349-5498c8f846c4",
        "instanceType": "Timing",
        "windowLower": "P30D",
        "windowUpper": "P60D"
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "Run-in Compliance",
        "instanceType": "Condition",
        "description": "Compliance threshold for randomization",
        "text": "Subjects must have >=80% compliance by pill count during the 2-week single-blind placebo run-in period."
      },
      {
        "id": "cond_2",
        "name": "eGFR Eligibility",
        "instanceType": "Condition",
        "description": "Renal function inclusion range",
        "text": "eGFR of >=30 to <90 mL/min/1.73m2 confirmed by central laboratory."
      },
      {
        "id": "cond_3",
        "name": "Albuminuria Eligibility",
        "instanceType": "Condition",
        "description": "UACR inclusion range",
        "text": "UACR of >300 mg/g to 5,000 mg/g (>33.9 mg/mmol to <=565.6 mg/mmol)."
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Screening to Run-in",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "screening",
        "toElementId": "run_in",
        "text": "Subjects meeting inclusion/exclusion criteria enter single-blind placebo run-in at Week -2."
      },
      {
        "id": "trans_2",
        "name": "Randomization",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "run_in",
        "toElementId": "double_blind_treatment",
        "text": "Compliant subjects randomized 1:1 to canagliflozin 100 mg or placebo."
      },
      {
        "id": "trans_3",
        "name": "Discontinuation for DKA",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Double-blind study drug should be permanently discontinued for any subject who experiences a serious adverse event of biochemically-confirmed DKA."
      },
      {
        "id": "trans_4",
        "name": "Renal Event Discontinuation",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Study medication is to be discontinued when chronic dialysis or renal transplant is initiated."
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Early Treatment Discontinuation",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Subjects who discontinue study drug prematurely should continue to attend all subsequent study visits until GTED."
      },
      {
        "id": "exit_2",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "The study ends at the Global Trial End Date (GTED) once the required number of primary efficacy events (844) is reached."
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "Interim Analysis",
        "timepointId": "event_driven",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Interim analysis conducted when 540 subjects meet the primary composite endpoint."
      }
    ],
    "summary": {
      "timingCount": 6,
      "conditionCount": 3,
      "transitionRuleCount": 4,
      "exitCount": 2
    }
  }
}